tirzepatide semaglutide effectiveness comparison versus Once Weekly in Patients with Type 2 Diabetes Semaglutide vs. Tirzepatide for Weight

Studies show 50% of lost weight typically returns within six months after discontinuation if lifestyle changes weren't sustained

Research interest includes adipose-tissue research models, NAD+ salvage pathway studies, and metabolic-research applications

According to Yucca Health's safety information pages, the most common side effects include: Gastrointestinal Effects: Nausea (most common, especially early on) Diarrhea Constipation Vomiting Indigestion and abdominal discomfort Feeling full quickly after eating Other Common Effects: Headache Fatigue Dizziness Managing Side Effects: Most patients find that nausea and gastrointestinal symptoms improve as the body adjusts to the medication

Novo Nordisk also launched an oral tablet form of Wegovy in 2025, making it the first oral GLP-1 approved for weight loss

Patients with certain genetic profiles experience more pronounced delayed gastric emptying, increasing sulfur burp frequency

The fastest way to manage nausea is to reduce meal sizes and avoid high-fat or sugary foods